A Phase I Study of Quisinostat (JNJ-26481585), an Oral...

Clinical Cancer Research 2013 / 08 Vol. 19; Iss. 15

A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors

Venugopal, B., Baird, R., Kristeleit, R. S., Plummer, R., Cowan, R., Stewart, A., Fourneau, N., Hellemans, P., Elsayed, Y., Mcclue, S., Smit, J. W., Forslund, A., Phelps, C., Camm, J., Evans, T. R. J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-13-0312
Date:
August, 2013
File:
PDF, 652 KB
english, 2013
Conversion to is in progress
Conversion to is failed